Recent Updates
Recently added Catalysts

Triesence

Phase 2

Glaucoma | Small molecule | Ophthalmology |Alcon Inc.|Last Updated: Jul 10, 2018

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedACTIVE_CONTROLLED
Total Trials1
Total Enrollment77
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT00853905Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?PHASE2 COMPLETED 77Feb 1, 2009Jan 1, 2012Jul 10, 20181 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Intraocular Pressure (IOP)
1 day, 1week, 1 month, 3 month and 6 month post-op visits

Intraocular pressure (IOP) was measured by applanation tonometry in millimeters of mercury (mmHg). Surgical success was determined if IOP was \<21mmHg and 20% less than baseline IOP. Failure was defined as inability to meet criteria for success or IOP was less than 5mmHg.

Secondary Endpoints
Anterior Chamber Inflammation (Flare)
1 month, 3 month and 6 month post-op visits
Bleb Appearance
1 day, 1 week, 1 month, 3 month and 6 month post-op visits
Patient Comfort
1 day, 1 week, 1 month, 3 month and 6 month post-op visits
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
Treatment 1(Triesence)EXPERIMENTALglaucoma surgery with 0.2cc Triesence adjunct.
Treatment 2 (balanced salt solution BSS)ACTIVE_COMPARATORglaucoma surgery with balanced salt solution, the standard technique.
Interventions
NameTypeDescription
TriesenceDRUGAt end of standard glaucoma surgery and the anterior chamber is reformed with balanced salt solution or viscoelastic to an adequate intraocular pressure, 0.2cc of Triesence will be delivered into the anterior chamber through the previously created paracentesis wound.
balanced salt solution BSSDRUGAt end of standard glaucoma surgery, the anterior chamber is reformed with balanced salt solution or viscoelastic to an adequate intraocular pressure.
Unlock Study Design Details
Eligibility Criteria
Age Range21 Years — N/A
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: * glaucoma patients requiring surgery (Trabeculectomy or Express Shunt; Trabeculectomy plus Phacoemulsification and Interocular Lens Implant; Baerveldt Tube; Ahmed Tube; Molteno Tube) * primary open angle glaucoma * primary angle-closure glaucoma * pseudoexfoliation glaucoma * p...

Countries:United States
Unlock Eligibility Criteria